Literature DB >> 20065137

Lost in translation: epidemiology, risk, and Alzheimer disease.

Mary Ganguli1, Walter A Kukull.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20065137      PMCID： PMC2806646          DOI： 10.1001/archneurol.2009.311

Source DB:  PubMed          Journal:  Arch Neurol        ISSN： 0003-9942


× No keyword cloud information.
  29 in total

1.  The value of risk-factor ("black-box") epidemiology.

Authors:  Sander Greenland; Manuela Gago-Dominguez; Jose Esteban Castelao
Journal:  Epidemiology       Date:  2004-09       Impact factor: 4.822

2.  Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study.

Authors:  Peter P Zandi; Michelle C Carlson; Brenda L Plassman; Kathleen A Welsh-Bohmer; Lawrence S Mayer; David C Steffens; John C S Breitner
Journal:  JAMA       Date:  2002-11-06       Impact factor: 56.272

3.  Head injury and risk of Alzheimer's disease by apolipoprotein E genotype.

Authors:  E S O'Meara; W A Kukull; L Sheppard; J D Bowen; W C McCormick; L Teri; M Pfanschmidt; J D Thompson; G D Schellenberg; E B Larson
Journal:  Am J Epidemiol       Date:  1997-09-01       Impact factor: 4.897

4.  APOE epsilon4 is not associated with Alzheimer's disease in elderly Nigerians.

Authors:  Oye Gureje; Adesola Ogunniyi; Olusegun Baiyewu; Brandon Price; Frederick W Unverzagt; Rebecca M Evans; Valerie Smith-Gamble; Kathleen A Lane; Sujuan Gao; Kathleen S Hall; Hugh C Hendrie; Jill R Murrell
Journal:  Ann Neurol       Date:  2006-01       Impact factor: 10.422

Review 5.  The neuroendocrinology of depression and chronic stress.

Authors:  S Checkley
Journal:  Br Med Bull       Date:  1996-07       Impact factor: 4.291

6.  History of depression as a risk factor for Alzheimer's disease.

Authors:  C E Speck; W A Kukull; D E Brenner; J D Bowen; W C McCormick; L Teri; M L Pfanschmidt; J D Thompson; E B Larson
Journal:  Epidemiology       Date:  1995-07       Impact factor: 4.822

7.  Synergistic effects of traumatic head injury and apolipoprotein-epsilon 4 in patients with Alzheimer's disease.

Authors:  R Mayeux; R Ottman; G Maestre; C Ngai; M X Tang; H Ginsberg; M Chun; B Tycko; M Shelanski
Journal:  Neurology       Date:  1995-03       Impact factor: 9.910

8.  Combined effects of APOE genotype, blood pressure, and antihypertensive drug use on incident AD.

Authors:  Chengxuan Qiu; Bengt Winblad; Johan Fastbom; Laura Fratiglioni
Journal:  Neurology       Date:  2003-09-09       Impact factor: 9.910

9.  Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study.

Authors:  Sally A Shumaker; Claudine Legault; Lewis Kuller; Stephen R Rapp; Leon Thal; Dorothy S Lane; Howard Fillit; Marcia L Stefanick; Susan L Hendrix; Cora E Lewis; Kamal Masaki; Laura H Coker
Journal:  JAMA       Date:  2004-06-23       Impact factor: 56.272

10.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.

Authors:  L A Farrer; L A Cupples; J L Haines; B Hyman; W A Kukull; R Mayeux; R H Myers; M A Pericak-Vance; N Risch; C M van Duijn
Journal:  JAMA       Date:  1997 Oct 22-29       Impact factor: 56.272
View more
  10 in total

1.  Engagement in reading and hobbies and risk of incident dementia: the MoVIES project.

Authors:  Tiffany F Hughes; Chung-Chou H Chang; Joni Vander Bilt; Mary Ganguli
Journal:  Am J Alzheimers Dis Other Demen       Date:  2010-08       Impact factor: 2.035

2.  Overview and findings from the religious orders study.

Authors:  David A Bennett; Julie A Schneider; Zoe Arvanitakis; Robert S Wilson
Journal:  Curr Alzheimer Res       Date:  2012-07       Impact factor: 3.498

3.  Promotion of cognitive health through cognitive activity in the aging population.

Authors:  Tiffany F Hughes
Journal:  Aging health       Date:  2010-02-01

4.  Smoking, death, and Alzheimer disease: a case of competing risks.

Authors:  Chung-Chou H Chang; Yongyun Zhao; Ching-Wen Lee; Mary Ganguli
Journal:  Alzheimer Dis Assoc Disord       Date:  2012 Oct-Dec       Impact factor: 2.703

Review 5.  Physical activity and mild cognitive impairment and Alzheimer's disease.

Authors:  Nicola T Lautenschlager; Kay Cox; Alexander F Kurz
Journal:  Curr Neurol Neurosci Rep       Date:  2010-09       Impact factor: 5.081

6.  Gene-environment interaction research and transgenic mouse models of Alzheimer's disease.

Authors:  L Chouliaras; A S R Sierksma; G Kenis; J Prickaerts; M A M Lemmens; I Brasnjevic; E L van Donkelaar; P Martinez-Martinez; M Losen; M H De Baets; N Kholod; F van Leeuwen; P R Hof; J van Os; H W M Steinbusch; D L A van den Hove; B P F Rutten
Journal:  Int J Alzheimers Dis       Date:  2010-10-05

7.  Changing scenario of neuropractice.

Authors:  Me Yeolekar
Journal:  J Neurosci Rural Pract       Date:  2011-01

8.  Synergistic interaction between APOE and family history of Alzheimer's disease on cerebral amyloid deposition and glucose metabolism.

Authors:  Dahyun Yi; Younghwa Lee; Min Soo Byun; Jun Ho Lee; Kang Ko; Bo Kyung Sohn; Young Min Choe; Hyo Jung Choi; Hyewon Baek; Chul-Ho Sohn; Yu Kyeong Kim; Dong Young Lee
Journal:  Alzheimers Res Ther       Date:  2018-08-23       Impact factor: 6.982

Review 9.  Perspectives in molecular imaging using staging biomarkers and immunotherapies in Alzheimer's disease.

Authors:  Benoît Leclerc; Abedelnasser Abulrob
Journal:  ScientificWorldJournal       Date:  2013-02-05

10.  Multi-time-point data preparation robustly reveals MCI and dementia risk factors.

Authors:  Daman Kaur; Magda Bucholc; David P Finn; Stephen Todd; KongFatt Wong-Lin; Paula L McClean
Journal:  Alzheimers Dement (Amst)       Date:  2020-10-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.